Hyperoxia, Postoperative Complication, Surgical Site Infection
Conditions
Keywords
Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
Brief summary
The iPROVE-O2 trial aims at comparing the efficacy of high and conventional FiO2 within a perioperative individualized ventilatory strategy to reduce the overall incidence of SSI.
Interventions
High FiO2 with a perioperative open lung strategy
Conventional FiO2 with a perioperative open lung strategy
Sponsors
Study design
Eligibility
Inclusion criteria
* Age not less than 18 * Planned abdominal surgery\> 2 hours. * Signed informed consent for participation in the study.
Exclusion criteria
* Age less than 18 years. * Pregnant or breast-feeding. * Patients with BMI \>35. * Syndrome of moderate or severe respiratory distress: PaO2/FiO2 \< 200 mmHg. * Heart failure: NYHA IV. * Hemodynamic failure: CI \<2.5 L/min/m2 and / or requirements before surgery ionotropic support. * Diagnosis or suspicion of intracranial hypertension (intracranial pressure\> 15 mmHg). * Mechanical ventilation in the last 15 days. * Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT). * Patient with preoperatively CPAP. * Participation in another experimental protocol at the time of intervention selection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical site infection | seven postoperative days |
Secondary
| Measure | Time frame |
|---|---|
| Systemic complications | seven postoperative days |
| Pulmonary complications | seven postoperative days |
| Systemic and pulmonary complications | thirty postoperative days |
Countries
Spain